Lupin, I'rom ink pact for biosimilar Denosumab Ruchika Sharma25 Aug 2022 12:30 PM ISTCurrently, Denosumab is available under two brands, Pralia and Ranmark.
Effects of denosumab easily reversible after discontinuation in RA patients on steroids: Study MD Editorial Team6 Dec 2021 9:00 AM ISTDenosumab discontinuation resulted in a gradual increase in bone turnover, which was associated with a return to baseline lumbar spine (LS) and total...
Study finds risk factors for vertebral fractures and bone loss after denosumab discontinuation MD Bureau14 March 2021 9:30 AM ISTDenosumab reduces bone resorption and improves bone mineral density (BMD). A recent study suggests that the age, treatment duration, and prior...
Cipla Gulf expands partnership with Alvotech for commercialization of 4 biosimilar medicines in Australia, New Zealand Ruchika Sharma2 March 2021 4:26 PM ISTMumbai: Cipla Limited today announced that the company's subsidiary, Cipla Gulf FZ LCC ("Cipla Gulf') is expanding its partnership with Alvotech for...
Denosumab may help prevent Revision Procedures Following Hip Replacement: Study Dr Satabdi Saha17 Jan 2021 5:15 PM ISTIn a recent study, the researchers investigated the effect of the human monoclonal antibody denosumab on osteolytic lesion activity in patients...
